STATE STREET CORP

Position in SABS — SAB Biotherapeutics, Inc.

CIK 93751 BOSTON, MA

Position in SABS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$2,070,240

+$1,785,936 QoQ

Shares Held

530,831

+615.1% QoQ

Ownership

0.583%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#22

of 86 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 42% Shared 0% None 58%

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. SABS ranks #272 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,871,459	$5,896,909,829
2	REGN	Regeneron Pharmaceuticals, Inc.	4,834,688	$3,014,621,355
3	INCY	Incyte Corp	9,722,336	$1,102,124,008
4	MRNA	Moderna, Inc.	15,726,193	$1,101,305,295
5	ALNY	Alnylam Pharmaceuticals, Inc.	3,555,689	$1,070,369,059
6	RVMD	Revolution Medicines, Inc.	4,897,051	$917,119,711
7	RPRX	Royalty Pharma plc	12,338,229	$691,804,500
8	INSM	INSMED Inc	6,052,174	$645,282,791

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,070,240	530,831	+615.1%	Shares	Defined	2026-08-07
2026-03-31	$284,304	74,231	+465.7%	Shares	Defined	2026-05-15
2025-12-31	$49,076	13,122	-83.8%	Shares	Defined	2026-02-13
2023-12-31	$55,893	81,241	0.0%	Shares	Defined	2024-02-14
2023-09-30	$51,181	81,241	0.0%	Shares	Defined	2023-11-14
2023-06-30	$67,430	81,241	0.0%	Shares	Defined	2023-08-14
2023-03-31	$35,746	81,241	0.0%	Shares	Defined	2023-05-15
2022-12-31	$47,932	81,241	0.0%	Shares	Defined	2023-05-15
2022-09-30	$56,949	81,241	0.0%	Shares	Defined	2022-11-15
2022-06-30	$117,799	81,241	+91.9%	Shares	Defined	2022-08-15
2022-03-31	$159,202	42,341	+244.2%	Shares	Defined	2022-05-16
2021-12-31	$96,063	12,300	—	Shares	Defined	2022-02-14
No filing history on record for this holder in this stock.